Comparison of the Efficacy of 1064‐ and 730‐nm Picosecond Lasers for Acquired Dermal Melanocytosis
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70123 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Kento Takaya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Lasers, Solid-State, Melanosis, Low-Level Light Therapy, Hyperpigmentation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acquired dermal melanocytosis (ADM) is a pigmentary lesion caused by melanocytes in the dermis. These conditions are refractory, and a consensus on treatment remains elusive.
Aims
To compare the efficacy of 730‐ and 1064‐nm picosecond lasers in the treatment of ADM and to supplement the comparison with a literature review. Patients: We retrospectively examined patients who underwent picosecond laser therapy between April 2021 and February 2024. Treatments were performed three times with spot irradiation using a 730‐nm laser (3‐mm spot, 1.7–1.8 J/cm 2 ; or 2‐mm spot, 2.5–3.25 J/cm 2 ) and a 1064‐nm laser (3‐mm spot, 3.1–4.0 J/cm 2 ). Two months after each procedure, patient satisfaction was evaluated using questionnaires, macroscopic findings were assessed using photographs, and melanin accumulation was analyzed using skin analysis software. Evaluations were conducted on a 4‐point scale (excellent, good, fair, and poor), with good or higher considered effective.
Results
Seventy‐eight and 83 patients were assigned to the 730‐ and 1064‐nm groups, respectively. After three sessions, the 730‐nm group exhibited superior outcomes in terms of subjective symptoms (patient satisfaction), objective findings, and software analysis improvements. The incidence of hyperpigmentation was 15.4% in the 1064‐nm group and 14.5% in the 730‐nm group, with no significant differences observed in the rates of other complications.
Conclusions
The use of a 730‐nm picosecond laser, which possesses high melanin selectivity, relatively deep penetration, and a short pulse width, suggests a potentially more effective treatment for ADM, compared to the effects of the conventional 1064‐nm wavelength, without increasing complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, Tokyo, Japan.
- Etoile Regina Clinic, Tokyo, Japan.
ORCID-Profile: Kento Takaya
Zitieren
APA
Takaya, K., & Kishi, K. (2025). Comparison of the Efficacy of 1064‐ and 730‐nm Picosecond Lasers for Acquired Dermal Melanocytosis. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70123
Vancouver
Takaya K, Kishi K. Comparison of the Efficacy of 1064‐ and 730‐nm Picosecond Lasers for Acquired Dermal Melanocytosis. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70123
BibTeX
@article{Takaya2025,
author = {Takaya, Kento and Kishi, Kazuo},
title = {Comparison of the Efficacy of 1064‐ and 730‐nm Picosecond Lasers for Acquired Dermal Melanocytosis},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70123}
}
EUVIMED